New Delhi: A US-based pharmaceutical company has bagged the contract from President Donald Trump’s administration to produce drugs that are used to fight coronavirus.
Phlow Corp, which has bagged the $354-million contract, said it had making pharmaceutical ingredients which can be used to produce medicines to treat COVID-19 patients.
The US administration’s move is considered as a strategy to counter the country’s heavy dependence on import of such ingredients. particularly from China and India.
The four-year contract, with an additional $458 million included as potential options, will enable the company to meet the shortfall of such drugs.
Following the outbreak of COVID pandemic, the US President had contacted Prime Minister Narendra Modi seeking such medicines which India had obliged.
Dubai: ODI cricket, Pakistan – they bring out the best in Virat Kohli. The Dubai… Read More
Cuttack: Three criminals were arrested by Choudwar police in Odisha’s Cuttack district for allegedly looting… Read More
Kolkata: Odisha FC fought gallantly in the lion’s den but finally returned empty-handed. Up against league… Read More
Kolkata: A West Bengal secondary board exam (Madhyamik) candidate recently took Artificial Intelligence (AI) to… Read More
New Delhi: A fourth batch of Indian nationals deported from the US arrived at Indira… Read More
Berhampur: Rushikulya river mouth in Odisha’s Ganjam district has emerged as a major rookery for… Read More
This website uses cookies.
